ATE16349T1 - Verfahren zur herstellung einer entzuendungshemmenden rindermilch. - Google Patents

Verfahren zur herstellung einer entzuendungshemmenden rindermilch.

Info

Publication number
ATE16349T1
ATE16349T1 AT81301877T AT81301877T ATE16349T1 AT E16349 T1 ATE16349 T1 AT E16349T1 AT 81301877 T AT81301877 T AT 81301877T AT 81301877 T AT81301877 T AT 81301877T AT E16349 T1 ATE16349 T1 AT E16349T1
Authority
AT
Austria
Prior art keywords
inflammatory
manufacture
bovine milk
milk
bovid
Prior art date
Application number
AT81301877T
Other languages
English (en)
Inventor
Lee R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Application granted granted Critical
Publication of ATE16349T1 publication Critical patent/ATE16349T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT81301877T 1981-04-28 1981-04-28 Verfahren zur herstellung einer entzuendungshemmenden rindermilch. ATE16349T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP81301877A EP0064103B1 (de) 1981-04-28 1981-04-28 Verfahren zur Herstellung einer entzündungshemmenden Rindermilch

Publications (1)

Publication Number Publication Date
ATE16349T1 true ATE16349T1 (de) 1985-11-15

Family

ID=8188287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81301877T ATE16349T1 (de) 1981-04-28 1981-04-28 Verfahren zur herstellung einer entzuendungshemmenden rindermilch.

Country Status (3)

Country Link
EP (1) EP0064103B1 (de)
AT (1) ATE16349T1 (de)
DE (1) DE3172807D1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
USRE33565E (en) * 1978-02-06 1991-04-02 Stolle Research And Development Corporation Prevention and treatment of rheumatioid arthritis
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
EP0127712B1 (de) * 1983-06-07 1989-01-11 The Stolle Research And Development Corporation Desodorant das bakterielle Antikörper enthält
US5106618A (en) * 1987-07-02 1992-04-21 Stolle Research And Development Corporation Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
EP0300102B1 (de) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung
JP2664906B2 (ja) * 1987-08-13 1997-10-22 ストール・リサーチ・アンド・デイベロップメント・コーポレーション 改良された哺乳類の免疫法
NZ505753A (en) * 1992-06-16 2004-11-26 Stolle Milk Biologics Inc The use of hyperimmune milk to increase longevity
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
ATE227557T1 (de) * 1995-04-28 2002-11-15 Sara Lee De Nv Verwendung von zahnpflegemitteln enthaltend bovines kolostrum
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
KR101540412B1 (ko) 2005-09-09 2015-07-29 머레이 걸번 코-어퍼러티브 컴퍼니 리미티드 근육 염증 감소용 유장 성장 인자 추출물의 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
OA02600A (fr) * 1966-06-27 1970-05-05 Merieux Charles Nouveau procédé de préparation d'immunes lactoglobulines.
FR1599671A (de) * 1966-06-27 1970-07-20
DE1617643B1 (de) * 1967-06-24 1971-02-11 Charles Merieux Verfahren zur Herstellung von Immun-Lactoglobulinen
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
GB1505513A (en) * 1975-05-23 1978-03-30 Stolle Res & Dev Dental caries inhibiting product
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
SE448344B (sv) * 1978-02-06 1987-02-16 Stolle Res & Dev Antikropp for behandling av reumatoid artrit samt sett att framstella denna

Also Published As

Publication number Publication date
DE3172807D1 (en) 1985-12-12
EP0064103B1 (de) 1985-11-06
EP0064103A1 (de) 1982-11-10

Similar Documents

Publication Publication Date Title
ATE16349T1 (de) Verfahren zur herstellung einer entzuendungshemmenden rindermilch.
DE69126281D1 (de) Verfahren zur Herstellung von Antikörpern
DE3787139D1 (de) Verfahren zur Erzeugung von Einkristall-Dünnschichten aus Halbleitergrundstoff.
ATE14569T1 (de) Verfahren zur herstellung von alkansaeureestern durch umlagerung von alpha-haloketalen.
AT382553B (de) Verfahren zur herstellung von behaeltern durch tiefziehen und durch dieses verfahren hergestellter behaelter
DE69300626D1 (de) Verfahren zur Herstellung von 19-Norvitamin-D-Verbindungen
ATE14597T1 (de) Verfahren zur enzymatischen herstellung von l-2- amino-4-methylphosphinobuttersaeure.
ATE131474T1 (de) Verfahren zur herstellung cyclischer carbonate
ATE5592T1 (de) Verfahren zur herstellung von 4'deoxydaunorubicin und 4'-deoxydoxorubicin, sowie 4'-epi-4'-trifluormethyl-sulfonyloxy-ntrifluoracetyldaunorubicin.
ATE82955T1 (de) Verfahren zur herstellung von o-substituierten hydroxylaminen.
ATE9689T1 (de) Verfahren zur herstellung von reaktiven, kupplungsfaehigen derivaten der schilddruesenhormone t3 und t4 und deren verwendung.
AT373602B (de) Verfahren zur herstellung von phosphorkohlenstoff-stickstoff-bindung enthaltenden verbindungen
DE3466678D1 (en) Process for the preparation of 1,4-butane-dialdehyde
ATA408579A (de) Verfahren zur herstellung neuer verbindungen
DE69012279D1 (de) Verfahren zur Herstellung ungesättigter Verbindungen.
ATA29679A (de) Verfahren zur herstellung von neuen analogen des beta h-endorphins
DD138197A1 (de) Verfahren zur herstellung von zement
PT73726A (de) Verfahren zur herstellung neuer 2-aminoimidazole
ATE139999T1 (de) Verfahren zur herstellung von fluormethyl- substituierter piperidin-carbodithioaten
ATE63121T1 (de) Verfahren zur herstellung von ifosfamid mit verbesserten eigenschaften.
JPS5799598A (en) Hapten antigen and its synthetic intermediate
ATE6933T1 (de) Verfahren zur herstellung von 4aminobutters[ureamid.
ATE16599T1 (de) Verfahren zur herstellung von 1,1'diphosphaferrocenen.
ATE26254T1 (de) Verfahren zur herstellung von 2,2,2 trifluoraethanol.
DE59501436D1 (de) Verfahren zur Herstellung von 2-Cyaniminothiazolidin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee